112 related articles for article (PubMed ID: 37001327)
1. Effect of LGR4/EGFR signaling on cell growth and cancer stem cell-like characteristics in liver cancer.
Liu Y; Zhang Y; Chen S; Zhong X; Liu Q
Cytokine; 2023 May; 165():156185. PubMed ID: 37001327
[TBL] [Abstract][Full Text] [Related]
2. Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway.
Bi Y; Zhang L; Song Y; Sun L; Mulholland MW; Yin Y; Zhang W
Gastroenterol Hepatol; 2024 Apr; 47(4):352-365. PubMed ID: 37437654
[TBL] [Abstract][Full Text] [Related]
3. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
[TBL] [Abstract][Full Text] [Related]
5. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
6. A Wnt-Independent LGR4-EGFR Signaling Axis in Cancer Metastasis.
Yue F; Jiang W; Ku AT; Young AIJ; Zhang W; Souto EP; Gao Y; Yu Z; Wang Y; Creighton CJ; Nagi C; Wang T; Hilsenbeck SG; Feng XH; Huang S; Coarfa C; Zhang XH; Liu Q; Lin X; Li Y
Cancer Res; 2021 Sep; 81(17):4441-4454. PubMed ID: 34099494
[TBL] [Abstract][Full Text] [Related]
7. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract][Full Text] [Related]
8. CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
Jang JW; Song Y; Kim SH; Kim JS; Kim KM; Choi EK; Kim J; Seo HR
Cancer Lett; 2017 Mar; 389():1-10. PubMed ID: 28034805
[TBL] [Abstract][Full Text] [Related]
9. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
10. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
11. Blockade of LGR4 inhibits proliferation and odonto/osteogenic differentiation of stem cells from apical papillae.
Zhou M; Guo S; Yuan L; Zhang Y; Zhang M; Chen H; Lu M; Yang J; Ma J
J Mol Histol; 2017 Dec; 48(5-6):389-401. PubMed ID: 28986711
[TBL] [Abstract][Full Text] [Related]
12. LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.
Cheng Q; Zheng H; Li M; Wang H; Guo X; Zheng Z; Chen C; Liu J; Zhan T; Li Z; Wu H; Han J; Liu L; Tang T; Chen Q; Du L
Cancer Lett; 2022 Aug; 540():215725. PubMed ID: 35561877
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.
Ma L; Zhang G; Miao XB; Deng XB; Wu Y; Liu Y; Jin ZR; Li XQ; Liu QZ; Sun DX; Testa JR; Yao KT; Xiao GH
FEBS J; 2013 May; 280(9):2027-41. PubMed ID: 23461856
[TBL] [Abstract][Full Text] [Related]
14. The Role of LGR4 (GPR48) in Normal and Cancer Processes.
Ordaz-Ramos A; Rosales-Gallegos VH; Melendez-Zajgla J; Maldonado V; Vazquez-Santillan K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946652
[TBL] [Abstract][Full Text] [Related]
15. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
[TBL] [Abstract][Full Text] [Related]
16. LGR4 maintains HGSOC cell epithelial phenotype and stem-like traits.
Wang Z; Yin P; Sun Y; Na L; Gao J; Wang W; Zhao C
Gynecol Oncol; 2020 Dec; 159(3):839-849. PubMed ID: 32980127
[TBL] [Abstract][Full Text] [Related]
17. Lgr4 promotes glioma cell proliferation through activation of Wnt signaling.
Yu CY; Liang GB; Du P; Liu YH
Asian Pac J Cancer Prev; 2013; 14(8):4907-11. PubMed ID: 24083766
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
19. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway.
Zhang H; Liang F; Yue J; Liu P; Wang J; Wang Z; Li H; Cheng D; Du J; Zhang K; Du P
Int J Oncol; 2020 Aug; 57(2):540-549. PubMed ID: 32626928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
